Literature DB >> 8027314

Bacteremia by multidrug-resistant Capnocytophaga sputigena.

J L Gomez-Garces1, J I Alos, J Sanchez, R Cogollos.   

Abstract

A case of bacteremia caused by a multiresistant strain of Capnocytophaga sputigena in a patient with hematological malignancy is described. The strain presented with a pattern of marked resistance to beta-lactams, with MICs of > 256 mg/liter for ampicillin, ticarcillin, piperacillin, cefazolin, and cefuroxime, 64 mg/liter for cefotaxime, and 32 mg/liter for ceftazidime. In addition, the MIC of ciprofloxacin was 16 mg/liter. Both of these groups of antimicrobial agents are frequently used in the empiric treatment of infections in immunocompromised patients. The appearance of resistant strains suggests the need for antimicrobial susceptibility studies in all patients with severe infections caused by Capnocytophaga spp. or other capnophilic organisms present in the oral microflora of these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027314      PMCID: PMC267185          DOI: 10.1128/jcm.32.4.1067-1069.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.

Authors:  D L Roscoe; S J Zemcov; D Thornber; R Wise; A M Clarke
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents.

Authors:  J L Rummens; B Gordts; H W Van Landuyt
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

3.  Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.

Authors:  D M Parenti; D R Snydman
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

4.  Capnocytophaga sepsis: a newly recognised clinical entity in granulocytopenic patients.

Authors:  S W Forlenza; M G Newman; A I Lipsey; S E Siegel; U Blachman
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

5.  Novel beta-lactamase from Capnocytophaga sp.

Authors:  J E Foweraker; P M Hawkey; J Heritage; H W Van Landuyt
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

6.  Studies of the microbiology of periodontosis.

Authors:  M G Newman; S S Socransky; E D Savitt; D A Propas; A Crawford
Journal:  J Periodontol       Date:  1976-07       Impact factor: 6.993

7.  Detection, identification, and comparison of Capnocytophaga, Bacteroides ochraceus, and DF-1.

Authors:  M G Newman; V L Sutter; M J Pickett; U Blachman; J R Greenwood; V Grinenko; D Citron
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

8.  Synonymy of strains of Center for Disease Control group DF-1 with species of Capnocytophaga.

Authors:  B L Williams; D Hollis; L V Holdeman
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

9.  In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones.

Authors:  G Arlet; M J Sanson-Le Pors; I M Casin; M Ortenberg; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

10.  Capnophilic and anaerobic bacteremia in neutropenic patients: an oral source.

Authors:  F Baquero; J Fernández; F Dronda; A Erice; J Pérez de Oteiza; J A Reguera; M Reig
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb
  10 in total
  13 in total

1.  Capnocytophaga lung abscess in a patient with metastatic neuroendocrine tumor.

Authors:  Raghu Thirumala; Urania Rappo; N Esther Babady; Mini Kamboj; Mohit Chawla
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 2.  Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria.

Authors:  James H Jorgensen
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Genetic analysis of an ambler class A extended-spectrum beta-lactamase from Capnocytophaga ochracea.

Authors:  Anne Jolivet-Gougeon; Zohreh Tamanai-Shacoori; Laurent Desbordes; Nathalie Burggraeve; Michel Cormier; Martine Bonnaure-Mallet
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 4.  Mixed bacteremia with Capnocytophaga sputigena and Escherichia coli following bone marrow transplantation: case report and review.

Authors:  J I García-Cía; J Esteban; F Santos-O'Connor; A Román; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-08       Impact factor: 3.267

5.  Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.

Authors:  Hélène Guillon; François Eb; Hedi Mammeri
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

6.  Brain abscess associated with multidrug-resistant Capnocytophaga ochracea infection.

Authors:  Hua-Kung Wang; Yee-Chun Chen; Lee-Jene Teng; Chien-Ching Hung; Mei-Lin Chen; Shin-Hei Du; Hui-Ju Pan; Po-Ren Hsueh; Shan-Chwen Chang
Journal:  J Clin Microbiol       Date:  2006-11-29       Impact factor: 5.948

7.  In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors.

Authors:  A Jolivet-Gougeon; A Buffet; C Dupuy; J L Sixou; M Bonnaure-Mallet; S David; M Cormier
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  Capnocytophaga sp. isolated from a cat with chronic sinusitis and rhinitis.

Authors:  Erin Frey; Barrak Pressler; James Guy; Christian Pitulle; Edward Breitschwerdt
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 9.  Antimicrobial peptides in the oral environment: expression and function in health and disease.

Authors:  Beverly A Dale; L Page Fredericks
Journal:  Curr Issues Mol Biol       Date:  2005-07       Impact factor: 2.081

10.  The Brief Case: Capnocytophaga sputigena Bacteremia in a 94-Year-Old Male with Type 2 Diabetes Mellitus, Pancytopenia, and Bronchopneumonia.

Authors:  Benjamin M Liu; Christopher P Carlisle; Mark A Fisher; Salika M Shakir
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.